By Rob Beatty, MD FACEP
Cardiac catheterization, known affectionately in the cardiology world as “cath,” is one of those procedures that sounds scarier than it is—until, of course, you’re the one lying on the table in a lead apron. But rest assured: cath isn’t just for show. It’s a cornerstone diagnostic and therapeutic tool in cardiovascular medicine. So, let’s dive into the common (and some less common) reasons your friendly neighborhood cardiologist might suggest poking around your coronary arteries. Spoiler alert: it’s not just because we love fancy imaging.
Suspected Coronary Artery Disease (CAD): The Usual Suspect
Let’s start with the obvious. The number one reason for cardiac catheterization is to diagnose coronary artery disease. If your patient complains of chest pain, shortness of breath, or that classic “elephant on the chest” feeling, you might just have a cath candidate.
Per the 2021 ACC/AHA Chest Pain Guidelines, coronary angiography is appropriate when there is high clinical suspicion for obstructive CAD and noninvasive testing suggests significant ischemia. Cardiac cath is the gold standard for diagnosing CAD because it allows direct visualization of coronary anatomy and, if necessary, immediate intervention with percutaneous coronary intervention (PCI).
Quick Pearl: If the stress test screams “trouble” or the patient has persistent angina despite medical therapy, it’s time to roll down to the cath lab.
Acute Coronary Syndromes: STEMI, NSTEMI, and All the Drama
Ah, the thrill of the ER call: “STEMI alert!” When patients present with acute coronary syndromes (ACS), especially ST-elevation myocardial infarction (STEMI), time is myocardium. Guidelines recommend immediate cath with PCI within 90 minutes of first medical contact (ideally 60, if you’re really on your game).
According to the 2017 ESC STEMI Guidelines and 2020 ACC/AHA updates, cardiac catheterization is class I indicated for:
- STEMI patients within 12 hours of symptom onset
- Patients with ongoing ischemia or hemodynamic instability, regardless of timeline
- High-risk NSTEMI/unstable angina patients within 24–72 hours
Fun Fact: If you’ve ever felt your pulse race when you hear “door-to-balloon time,” welcome to the club. We have cath lab coffee mugs.
Heart Failure with Reduced Ejection Fraction (HFrEF): When the Pump Isn’t Pumping
When your patient shows up with bilateral pitting edema, rales, and a jugular vein you can see from across the room, heart failure is on the menu. The workup often includes echo and natriuretic peptides, but when HFrEF is confirmed (EF <40%) and the etiology is unclear, cardiac catheterization can help distinguish between ischemic and non-ischemic cardiomyopathy.
The ACC/AHA 2022 Heart Failure Guidelines recommend ischemic evaluation in new HFrEF cases. If CAD is suspected as the culprit, a cath is not just helpful—it’s essential.
Clinical Pearls: An abnormal stress test, regional wall motion abnormalities, or a suspicious ECG makes a strong case for a trip to the cath lab. Because you can’t fix what you don’t visualize.
Preoperative Evaluation in High-Risk Patients: The Surgical Stress Test
Before major non-cardiac surgery, especially vascular surgery, patients with known or suspected CAD often require risk stratification. If they can’t perform adequate exercise testing, or if noninvasive testing is inconclusive, cardiac cath may be indicated.
Per the 2014 ACC/AHA Perioperative Guidelines, angiography is reasonable in patients with:
- Elevated perioperative risk and poor functional capacity
- Positive or indeterminate noninvasive tests
- History of angina or prior MI with suspected incomplete revascularization
Translation: If your patient huffs and puffs going from bed to bathroom, and they’re scheduled for aortic aneurysm repair, you may want to peek at their coronaries before you put them under.
Valvular Heart Disease: More Than Just a Click or Murmur
Not all heart murmurs are created equal. When echocardiography shows severe aortic stenosis, mitral regurgitation, or other structural issues—and the patient is being evaluated for valve surgery—a coronary angiogram is often performed preoperatively to assess for concomitant CAD.
The 2020 ACC/AHA Valvular Guidelines recommend coronary angiography in:
- Men ≥40 and postmenopausal women undergoing valve surgery
- Patients with chest pain or risk factors for CAD
Bonus Round: In transcatheter aortic valve replacement (TAVR) candidates, cath is often done to prep the battlefield for valve deployment. No surprises allowed.
Congenital Heart Disease: Plumbing Problems from Birth
In the world of pediatric and adult congenital heart disease, cardiac cath provides both diagnostic and therapeutic options. It’s particularly useful for assessing intracardiac shunts, pressure gradients, and pulmonary vascular resistance.
The 2018 AHA/ACC Guidelines for the Management of Adults with Congenital Heart Disease suggest cath when echocardiography is inconclusive or when surgical/interventional planning is required. Think of it as advanced blueprinting for a fixer-upper heart.
Pro Tip: Cardiac cath also plays a major role in congenital interventions—like ASD/PFO closure or balloon valvuloplasty. Who says you can’t teach an old heart new tricks?
Cardiac Transplant Evaluation: Because Second Hearts Deserve First-Class Evaluation
Patients being evaluated for heart transplant will undergo a battery of tests. Among them: right heart catheterization to assess pulmonary pressures and left heart cath to rule out CAD.
The ISHLT and AHA guidelines mandate cath as part of the pre-transplant workup. Right heart cath is especially critical when assessing for pulmonary hypertension—one of the key determinants of post-transplant survival.
Fun(ish) Fact: In some transplant centers, this is practically a rite of passage. “Welcome to transplant workup—we’ll be threading a catheter into your pulmonary artery now.”
Routine Cardiac Screening: Who Gets What, and When?
Let’s address the elephant in the waiting room: should we be doing caths for screening? In a word: no. That’s what stress testing is for—unless you’re aiming to win the award for “Most Unnecessary Procedure.”
For asymptomatic individuals, routine screening typically involves:
- Exercise Treadmill Test (ETT): Best for patients with intermediate pre-test probability and good functional capacity.
- Nuclear Stress Test: Uses myocardial perfusion imaging to detect ischemia; helpful in those unable to exercise.
- Stress Echocardiography: Provides wall motion assessment during exercise or dobutamine infusion.
- Coronary CT Angiography (CCTA): Great non-invasive tool for low-to-intermediate risk patients with chest pain.
Guidelines: The 2021 ACC/AHA Chest Pain Guideline emphasizes starting with non-invasive testing for most stable patients. Cath comes into play when those tests show moderate to severe ischemia, or when patients fail medical therapy.
Conclusion: Cath Lab—Not Just a Place, a Lifestyle
Cardiac catheterization is a powerful, versatile tool in the management of cardiovascular disease. From emergency STEMIs to elective valve repairs and transplant evaluations, cath helps us see what we’re dealing with—and act accordingly.
But like any tool, it’s all about using it wisely. Guidelines exist to ensure we don’t over-cath (or under-cath) patients who could benefit from either diagnosis or intervention. Understanding the indications isn’t just academic—it’s critical to providing high-quality, evidence-based care. And hey, if we can have a little fun while navigating complex coronary anatomy, even better.
If you want to level up your ECG and cardiology interpretation skills, don’t miss the comprehensive course over at Provider Practice Essentials. It’s practical, high-yield, and maybe even a little fun. Your future cath lab consults will thank you.
References
- ACC/AHA Task Force. (2021). 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain. Journal of the American College of Cardiology, 78(22), e187–e285.
- Ponikowski, P., Voors, A. A., et al. (2022). 2022 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 43(36), 2985–2993.
- Neumann, F. J., et al. (2019). ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407–477.
- Otto, C. M., et al. (2020). 2020 ACC/AHA guideline for the management of patients with valvular heart disease. Journal of the American College of Cardiology, 77(4), e25–e197.
Ready to sharpen your cardiology game? Visit Provider Practice Essentials ECG and Cardiology Course and learn from experienced clinicians. It’s more exciting than watching contrast zip through a left main, and that’s saying something.